Topic: Papers from the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group
Guest Editor(s)
Dr. Godefridus J. (Frits) Peters
Amsterdam UMC, location VUMC, Laboratory Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Department of Biochemistry, Medical University of Gdansk, Gdansk, Poland.
Dr. Elisa Giovannetti
Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.
Special Issue Introduction
Cancer Drug Resistance is cooperating with the Meeting of the European Organization of Research and Treatment of Cancer (EORTC) - Pharmacology and Molecular Mechanisms (PAMM) Group (https://www.pamm-meeting.com/) and launching a Special Conference Issue. The 44th Meeting of EORTC - PAMM Group will be held on February 7th to 10th, 2024 in Marseille, France. The PAMM EORTC meeting is a unique blend of translational and clinical research in oncology - covering the latest innovations in targeted therapies and immunotherapies, experimental therapeutics, precision medicine and cutting-edge oncology. The Special Issue will focus on a selection of papers from the conference to cover advances in cancer drug resistance.
Keywords
Cancer drug discovery, mechanisms of action of novel drugs, drug resistance
Submission Deadline
31 Aug 2024
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/cdr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=cdr&SpecialIssueId=CDR221103
Submission Deadline: 31 Aug 2024
Contacts: Susan Song, Managing Editor, susan@cdrjournal.com
